DPHARMA
Quarterly rpt on consolidated results for the financial period ended 31/12/2006
CCM DUOPHARMA BIOTECH BERHAD |
Financial Year End | 31/12/2006 |
Quarter | 4 |
Quarterly report for the financial period ended | 31/12/2006 |
The figures | have not been audited |
SUMMARY OF KEY FINANCIAL INFORMATION31/12/2006 |
INDIVIDUAL PERIOD | CUMULATIVE PERIOD | ||||
CURRENT YEAR QUARTER | PRECEDING YEAR CORRESPONDING QUARTER | CURRENT YEAR TO DATE | PRECEDING YEAR CORRESPONDING PERIOD | ||
31/12/2006 | 31/12/2005 | 31/12/2006 | 31/12/2005 | ||
RM'000 | RM'000 | RM'000 | RM'000 | ||
1 | Revenue | 23,975 | 22,895 | 105,100 | 94,298 |
2 | Profit/(loss) before tax | 7,491 | 8,417 | 38,094 | 33,459 |
3 | Profit/(loss) for the period | 6,240 | 5,981 | 28,979 | 23,513 |
4 | Profit/(loss) attributable to ordinary equity holders of the parent | 6,240 | 5,981 | 28,979 | 23,513 |
5 | Basic earnings/(loss) per share (sen) | 4.50 | 4.29 | 20.89 | 17.54 |
6 | Proposed/Declared dividend per share (sen) | 14.50 | 17.50 | 21.50 | 17.50 |
AS AT END OF CURRENT QUARTER | AS AT PRECEDING FINANCIAL YEAR END | ||||
7 | Net assets per share attributable to ordinary equity holders of the parent (RM) | 1.0400 | 1.0100 |
Note: For full text of the above announcement, please access KLSE Web site at www.klse.com.my
Announcement Info
Company Name | CCM DUOPHARMA BIOTECH BERHAD |
Stock Name | CCMDBIO |
Date Announced | 22 Feb 2007 |
Category | Financial Results |
Reference No | CS-070221-60413 |